Clinico-pathologic correlation of Hodgkin's disease cases with versus cases without tissue eosinophilia
| Factors . | No Eosinophilia . | Eosinophilia . |
|---|---|---|
| Age | ||
| <20 | 10% | 9% |
| 20-30 | 32% | 40% |
| 30-40 | 27% | 25% |
| 40-50 | 14% | 12% |
| 50-60 | 12% | 9% |
| >60 | 5% | 5% |
| Gender | ||
| Male | 54% | 59% |
| Female | 46% | 41% |
| Histology | ||
| LP/NS1/LRC | 69% | 56% |
| NS2/MC/LD | 31% | 44% |
| Stage | ||
| I | 14% | 11% |
| II | 40% | 46% |
| III | 30% | 29% |
| IV | 16% | 14% |
| B-symptoms | ||
| Yes | 39% | 42% |
| Karnofsky Index | ||
| 9-10 | 90% | 89% |
| <9 | 10% | 11% |
| Large mediastinal mass | 18% | 21% |
| Extranodal spread | 23% | 23% |
| High ESR | 43% | 53% |
| >3 nodes areas involved | 56% | 60% |
| Hemoglobine (Hb) | ||
| <12 (m)/<10.5 (f) | 16% | 14% |
| Serum albumin | ||
| <4 g/dL | 35% | 37% |
| Lactate dehydrogenase (LDH) | ||
| >400 U | 2.9% | 2.3% |
| Alkaline phosphatase (AP) | ||
| >230 U | 14% | 15% |
| Lymphocytes as % of white blood cells | ||
| <10% | 21% | 26% |
| Factors . | No Eosinophilia . | Eosinophilia . |
|---|---|---|
| Age | ||
| <20 | 10% | 9% |
| 20-30 | 32% | 40% |
| 30-40 | 27% | 25% |
| 40-50 | 14% | 12% |
| 50-60 | 12% | 9% |
| >60 | 5% | 5% |
| Gender | ||
| Male | 54% | 59% |
| Female | 46% | 41% |
| Histology | ||
| LP/NS1/LRC | 69% | 56% |
| NS2/MC/LD | 31% | 44% |
| Stage | ||
| I | 14% | 11% |
| II | 40% | 46% |
| III | 30% | 29% |
| IV | 16% | 14% |
| B-symptoms | ||
| Yes | 39% | 42% |
| Karnofsky Index | ||
| 9-10 | 90% | 89% |
| <9 | 10% | 11% |
| Large mediastinal mass | 18% | 21% |
| Extranodal spread | 23% | 23% |
| High ESR | 43% | 53% |
| >3 nodes areas involved | 56% | 60% |
| Hemoglobine (Hb) | ||
| <12 (m)/<10.5 (f) | 16% | 14% |
| Serum albumin | ||
| <4 g/dL | 35% | 37% |
| Lactate dehydrogenase (LDH) | ||
| >400 U | 2.9% | 2.3% |
| Alkaline phosphatase (AP) | ||
| >230 U | 14% | 15% |
| Lymphocytes as % of white blood cells | ||
| <10% | 21% | 26% |